Chitosan-based rechargeable long-term antimicrobial and biofilm-controlling systems

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 4, 2009, Pages 960-967

  Cao, Zhengbing ^a   Sun, Yuyu ^a  

^a BioSNTR   (United States)

Author keywords

Antimicrobial; Biofilm controlling; Chitosan; Rechargeable

Indexed keywords

ANTIMICROBIAL; CATIONIC POLYMERS; CONTROLLING SYSTEM; DRUG RELEASE MECHANISM; GRAM-POSITIVE BACTERIUM; IONIC COMPLEX; MEDICAL DEVICES; NEW SYSTEM; POTENTIAL APPLICATIONS; RECHARGEABLE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIA; BIOFILMS; BIOFILTERS; CHITOSAN; DYES;

CHITIN;

CHITOSAN; RIFAMPICIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; CONTROLLED STUDY; DEVICE INFECTION; DRUG BINDING; DRUG INHIBITION; DRUG RELEASE; DRUG STRUCTURE; LONG TERM EXPOSURE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SUSTAINED DRUG RELEASE;

ANTI-INFECTIVE AGENTS; BIOFILMS; CHITOSAN; DRUG DELIVERY SYSTEMS; MICROBIAL SENSITIVITY TESTS; RIFAMPIN; SOLUTIONS; SOLVENTS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TIME FACTORS;

EID: 66249087275     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32040     Document Type: Article

References (44)

1. Eiff CV, Jansen B, Kohnen W, Becker K. Infections associated with medical devices. Drugs 2005;65:179-214.
2. Gristina AG. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 1987;37:1588-1595.
3. Dankert J, Hogt AH, Feijen J. Biomedical polymers: Bacterial adhesion, colonization, and infection. CRC Crit Rev Biocom- pat 1986;2:219-301.
4. Stoodley LH, Costerton JW, Stoodley P. Bacterial biofilms: From the natural environment to infectious diseases. Nature Rev 2004;2:95-108.
5. Chaiban G, Hanna H, Dvorak T, Raad I. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: A novel antiseptic agent. J Antimicrob Chemother 2005;55:51-56.
6. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD, Quade D, Shachtman RH, Schaberg DR, Shah BV, Schatz GD. Nosocomial infections in US hospitals, 1975- 1976: Estimated frequency by selected characteristics of patients. Am J Med 1981;70:947-959.
7. National Nosocomial Infections Surveillance System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;31:491-498.
8. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Rey- naga E, Valles J. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027-1030.
9. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter- related bloodstream infection in the surgical intensive care unit. Arch Surg 2001;136:229-234.
10. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
11. Mermel LA. Correction: Catheter-related bloodstream infections. Ann Intern Med 2000;133:395.
12. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887-892.
13. Saint S, Savel RH, Matthay MA. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Crit Care Med 2002;165: 1475-1479.
14. Stickler DJ. Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: A perspective from the study of catheter biofilms. J Appl Microbiol Sym Suppl 2002;92:163S-170S.
15. Jass J, Surman S, Walker J, editors. Medical Biofilms Detection Prevention and Control. West Sussex England: Wiley; 2003.
16. An YH, Friedman RJ, editors. Handbook of Bacterial Adhesion Principles, Methods, and Applications. New York: Humana Press; 2000.
17. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Gris- wold JA, Auer M, Hamood AN, Rumbaugh KP. Pseudomo- nas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 2007;75:3715-3721.
18. Mermel LA. New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis 2001;7: 197-199.
19. Swidsinski A, Loening-Baucke V, Bengmark S, Scholze J, Doerffel Y. Bacterial biofilm suppression with antibiotics for ulcerative and indeterminate colitis: Consequences of aggressive treatment. Arch Med Res 2008;39:198-204.
20. Romero R, Schaudinn C, Kusanovic JP, Gorur A, Gotsch F, Webster P, Nhan-Chang CL, Erez O, Kim CJ, Espinoza J, Goncalves LF, Vaisbuch E, Mazaki-Tovi S, Hassan SS, Costerton JW. Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol 2008;198:135 el-e5.
21. Talsma SS. Biofilms on medical devices. Home Health Nurse 2007;25:589-594.
22. Devine DA, Percival RS, Wood DJ, Tuthill TJ, Kite P, Killing- ton RA, Marsh PD. Inhibition of biofilms associated with dentures and toothbrushes by tetrasodium EDTA. J Appl Microbiol 2007;103:2516-2524.
23. Stobie N, Duffy B, McCormack DE, Colreavy J, Hidalgo M, McHale P, Hinder SJ. Prevention of Staphylococcus epidermidis biofilm formation using a low-temperature processed silver- doped phenyltriethoxysilane sol-gel coating. Biomaterials 2008;29:963-969.
24. Costerton JW, Chen KJ, Geesey GC, Ladd TI, Nickel JC, Das- gupta M, Marrie TJ. Bacteria biofilms in nature and disease. Annu Rev Microbiol 1987;41:435-464.
25. Pai MP, Pendland SL, Danziger LH. Antimicrobial-coated/ bonded and-impregnated intravascular catheters. Ann Phar- macother 2001;35:1255-1263.
26. Harvey RA, Alcid DV, Greco RS. Antibiotic bonding to poly- tetrafluoroethylene with tridodecylmethylammonium chloride. Surgery 1982;92:504-512.
27. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996;173:418-424.
28. Gaylord MS, Pittman PA, Bartness J, Tuinman AA, Lorch V. Release of benzalkonium chloride from a heparin-bonded umbilical catheter with resultant factitious hypernatremia and hyperkalemia. Pediatrics 1991;87:631-635.
29. Donelli G, Francolin I, Piozzi A, Di Rosa R, Marconi W. New polymer-antibiotic systems to inhibit bacterial biofilm formation: A suitable approach to prevent central venous catheter- associated infections. J Chemother 2002;14:501-507.
30. Ruggeri V, Francolini I, Donelli G, Piozzi A. Synthesis, characterization, and in vitro activity of antibiotic releasing poly- urethanes to prevent bacterial resistance. J Biomed Mater Res A 2007;81:287-298.
31. Aoki T, Iskandar S, Yoshida T, Takahashi K, Hattori M. Reduced immunogenicity of beta-lactoglobulin by conjugating with chitosan. Biosci Biotechnol Biochem 2006;70:2349-2356.
32. Fan LH, Du YM, Zhang BZ, Yang JH, Zhou JP, Kennedy JF. Preparation and properties of alginate/carboxyrnethyl chitosan blend fibers. Carbohyd Polym 2006;65:447-452.
33. Rabea EI, Badawy ME, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 2003;4:1457-1465.
34. Sudarshan NR, Hoover DG, Knorr D. Antibacterial action of chitosan. Food Biotechnol 1992;6:257-272.
35. Lee KY, Ha WS, Park WH. Blood compatibility and biode- gradability of partially N-acylated chitosan derivatives. Bio- materials 1995;16:1211-1216.
36. Fukuda H, Kikuchi Y. In vitro clot formation on the polyelec- trolyte complexes of sodium dextran surface with chitosan. J Biomed Mater Res 1978;12:531-539.
37. Zeng XF, Ruckenstein E. Control of pore sizes in macropo- rous chitosan and chitin membranes. Ind Eng Chem Res 1996;35:4169-4175.
38. Sherertz RJ, Forman DM, Solomon DD. Efficacy of dicloxacil- lin-coated polyurethane catheters in preventing subcutaneous staphylococcus aureus infection in mice. Antimicrob Agents Chemother 1989;33:1174-1178.
39. Bassetti S, Hu J, D'Agostino RB Jr, Sherertz RJ. In vitro zones of inhibition of coated vascular catheters predict efficacy in preventing catheter infection with staphylococcus aureus in vivo. Eur J Clin Microbiol Infect Dis 2000;19:612- 617.
40. Luo J, Sun YY. Acyclic N-halamine-based fibrous materials: Preparation, characterization, and biocidal functions. J Polym Sci Polym Chem 2006;44:3588-3600.
41. Singh M, Lumpkin JA, Rosenblatt J. Mathematical modeling of drug release from hydrogel matrices via a diffusion coupled with desorption mechanism. J Control Release 1994; 32:17-25.
42. Carratala J. The antibiotic-lock technique for therapy of "highly needed" infected catheters. Clin Microbiol Infect 2002;8:282-289.
43. Segarra-Newnham M, Martin-Cooper EM. Antibiotic lock technique: A review of the literature. Ann Pharmacother 2005;39:311-318.
44. Bestul MB, Vandenbussche HL. Antibiotic lock technique: Review of the literature. Pharmacotherapy 2005;25:211-227.